Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of sulfamonomethoxine derivative in preparation of antitumor drugs

The technology of sulfamonomethoxine and antitumor drug is applied in the application field of sulfamonomethoxine derivatives in the preparation of antitumor drugs, and achieves the effects of good inhibitory effect, good application prospect and obvious inhibitory effect.

Active Publication Date: 2020-07-14
SUN YAT SEN UNIV
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Its tumor-related effects have not been reported

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of sulfamonomethoxine derivative in preparation of antitumor drugs
  • Application of sulfamonomethoxine derivative in preparation of antitumor drugs
  • Application of sulfamonomethoxine derivative in preparation of antitumor drugs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Compound Sulfamono-methoxine (Sulfamono-methoxine), cpd-1, cpd-2, cpd-3, cpd-4 and cpd-5 inhibition of ALDOA activity assay:

[0042] The expressed and purified ALDOA protein was added to the 96-well plate according to different concentration gradients, and the ALDOA activity was determined by the aldolase activity colorimetric assay method. In particular ALDOA activity is determined by a colorimetric product whose absorbance at 450 nm is proportional to ALDOA activity. One unit of ALDOA is defined as the amount of enzyme that produces 1.0uM NADH per minute at a pH of 7.2 at 37°C ( figure 1 ).

Embodiment 2

[0043] Example 2: Compound Sulfamono-methoxine and cpd-5 inhibit ALDOA protein expression assay

[0044] Liver cancer, lung cancer, and pancreatic cancer cells were inoculated into 96-well plates at 1,000 cells per well, and cultured in 100 μl 10% FBS RPMI1640 culture medium. After culturing in an incubator for 24 hours, the cells were divided into groups, with 3 replicates in each group. Add the compounds Sulfamono-methoxine and cpd-5 in a 2-fold gradient, continue culturing until a specific detection time, collect the purified protein from the cells, add it to a 96-well plate that has been pre-bound with ALDOA antibody, add HRP-bound avidin for incubation, and add TMB Color development after the substrate solution, after adding sulfuric acid solution to terminate the enzyme substrate reaction, measure the color change at a wavelength of 450nm, and calculate the protein concentration of ALDOA after compound treatment ( figure 2 and image 3 ).

Embodiment 3

[0045] Example 3: Compound Sulfamono-methoxine and cpd-5 inhibit tumor cell viability assay

[0046] Liver cancer, lung cancer, and pancreatic cancer cells were inoculated into 96-well plates at 1,000 cells per well, and cultured in 100 μl 10% FBS RPMI1640 culture medium. After culturing in an incubator for 24 hours, the cells were divided into groups, with 3 replicates in each group. Add compounds Sulfamono-methoxine and cpd-5 in a 2-fold gradient and continue culturing until a specific detection time, add 10 μl CCK8 to each well, and incubate for 0.5-4 hours depending on the cells, use a microplate reader to detect cell viability at a wavelength of 450 nm, and calculate IC50( Figure 4 and Figure 5 ).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of a sulfamonomethoxine derivative in preparation of antitumor drugs. The structure of the derivative is shown in the specification. The derivative disclosed by theinvention can specifically inhibit the activity of fructose diphosphate aldolase A, and the new application of sulfamonomethoxine series compounds is expanded. The derivative disclosed by the invention can be used for preparing the antitumor drugs, particularly has a good inhibiting effect on hepatoma carcinoma cells, pancreatic cancer cells and lung cancer cells, also has an obvious inhibiting effect on the growth of mouse hepatoma carcinoma PDX tumors, and has a good application prospect.

Description

technical field [0001] The present invention relates to the technical field of medicine, more specifically, relates to the application of a sulfamethoxine derivative in the preparation of antitumor drugs, in particular, the sulfamethoxine derivative is used as a fructose diphosphate aldolase A inhibitor exerts an antitumor effect. [0002] technical background [0003] As an important cause of death worldwide, malignant tumors seriously threaten human life and health. According to the analysis report on the prevalence of malignant tumors in China released by the National Cancer Center in 2019, the number of new cases of malignant tumors in the country in 2015 was about 3.929 million, resulting in about 2.338 million deaths, and the annual medical expenses caused by malignant tumors exceeded 2,200. billion yuan. The high incidence of malignant tumors seriously threatens our national health and causes huge economic losses. [0004] Fructose diphosphate aldolase A (ALDOA) ​​i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/635A61P35/00
CPCA61K31/635A61P35/00
Inventor 万国辉牛艺卜宪章
Owner SUN YAT SEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com